Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2001;17(9):847–853. doi: 10.1023/A:1015653608151

Balkan endemic nephropathy in Vratza, Bulgaria, 1964–1987: An epidemiologic analysis of population-based disease registers

Plamen S Dimitrov 1,2, Valeri A Simeonov 3, Aryeh D Stein 4
PMCID: PMC7087956  PMID: 12081104

Abstract

Balkan Endemic Nephropathy (BEN), first described in 1956 in Vratza region, Bulgaria, may result from prolonged, chronic exposure to environmental toxicants, but the underlying etiologic factors remain elusive. There has been no recent systematic characterization of the epidemiology of this disease. Recently, it has been suggested that the incidence of the disease is decreasing. We therefore abstracted data from registers of patients in 21 affected villages and the town of Vratza, Bulgaria maintained from 1964 through 1987. In 1964, the prevalence of BEN was 6.0 per 1000 inhabitants; among residents of the affected villages, the prevalence was 12.3 per 1000. From 1965 to 1975 the incidence rate was 0.7 per 1000 person-years, and from 1976 to 1987 the incidence rate was 0.3 per 1000 person-years (rate ratio 0.43; p < 0.001). Incidence was much lower in Vratza town; among residents of affected villages, the period-specific rates were 1.7 and 0.8 per 1000 per year, respectively (rate ratio 0.47; p < 0.01). These trends were consistent across all villages for which registers were maintained. Median survival following registration increased from 2.0 to 5.0 years over the same period (p < 0.001). BEN appears to be decreasing in incidence in this region.

Keywords: Balkan Endemic Nephropathy, Descriptive epidemiology, Kidney disease, Survival, Time trends

References

  • 1.Tanchev Y, Evstatiev Z, Dorossiev D, Pencheva J, Tzvetkova G. Studies on the nephritides in the District of Vratza. Savremena Medicina. 1956;7:14–29. [Google Scholar]
  • 2.Krogh P. Role of ochratoxin in disease causation. Food Chem Toxicol. 1992;30:213–224. doi: 10.1016/0278-6915(92)90036-k. [DOI] [PubMed] [Google Scholar]
  • 3.Maaroufi K, Achour A, Betbeder AM, et al. Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: Correlation with chronic interstitial nephropathy in Tunisia. Arch Toxicol. 1995;69:552–558. doi: 10.1007/s002040050211. [DOI] [PubMed] [Google Scholar]
  • 4.Vrabcheva T, Usleber E, Dietrich R, Martlbauer E. Co-occurrence of ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy. J Agr Food Chem. 2000;48:2483–2488. doi: 10.1021/jf990891y. [DOI] [PubMed] [Google Scholar]
  • 5.Tatu CA, Orem WH, Finkelman RB, Feder GL. The etiology of Balkan endemic nephropathy: Still more questions than answers. Environ Health Perspect. 1998;106:689–700. doi: 10.1289/ehp.106-1533478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wedeen RP. Environmental renal disease: lead, cadmium and Balkan endemic nephropathy. Kidney Int. 1991;34:S4–S8. [PubMed] [Google Scholar]
  • 7.Maksimovic Z. Trace element de.ciency and Balkan endemic nephropathy. In: Strahinjic S, Stefanovic V, editors. Etiology of endemic (Balkan) nephropathy. Proceedings of the 6th Symposium on Endemic (Balkan) Nephropathy. Nis: University Press; 1987. pp. 43–47. [Google Scholar]
  • 8.Cosyns JP, Jadoul M, Squifflet JP, De Plaen JF, Ferluga D, van Ypersele de Strihou C. Chinese herbs nephropathy: A clue to Balkan endemic nephropathy? Kidney Int. 1994;45:1680–1688. doi: 10.1038/ki.1994.220. [DOI] [PubMed] [Google Scholar]
  • 9.Uzelac-Keserovic B, Vasic D, Ikonomovski J, Bojanic N, Apostolov K. Isolation of a coronavirus from urinary tract tumours of endemic Balkan nephropathy patients (letter) Nephron. 2000;86:93–94. doi: 10.1159/000045720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kraus K. Studies of Balkan Endemic Nephropathy. Zeitschr for Arztliche Fortbildung. 1996;60:829–834. [PubMed] [Google Scholar]
  • 11.Toncheva D, Dimitrov T, Stojanova S. Etiology of Balkan endemic nephropathy: A multifactorial disease? Eur J Epidemiol. 1998;14:389–394. doi: 10.1023/a:1007445120729. [DOI] [PubMed] [Google Scholar]
  • 12.Toncheva D, Dimitrov T. Genetic predisposition to Balkan endemic nephropathy. Nephron. 1996;72:564–569. doi: 10.1159/000188940. [DOI] [PubMed] [Google Scholar]
  • 13.Ganev VS, Petropoulos EA. In: Lekkas T., editor. Balkan endemic nephropathy and its putative environmental and genetic causes; Mytilene, Greece: University of the Aegean Press; 1999. pp. 11–21. [Google Scholar]
  • 14.Tanchev Y, Dorossiev D. The first clinical description of Balkan endemic nephropathy (1956) and its validity 35 years later. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H, editors. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours. Lyon: International Agency for Research on Cancer; 1991. pp. 21–28. [PubMed] [Google Scholar]
  • 15.Chernozemsky IM. Balkan endemic nephropathy and the associated tumours of the urinary system: A summary of epidemiological features in Bulgaria. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H, editors. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours. Lyon: International Agency for Research on Cancer; 1991. pp. 3–4. [PubMed] [Google Scholar]
  • 16.Cukuranovic R, Petrovic B, Cukuranovic Z, Stefanovic V. Balkan endemic nephropathy: A decreasing incidence of the disease. Pathol Biol. 2000;48:558–561. [PubMed] [Google Scholar]
  • 17.Stefanovic V, Radenkovic S, Cukuranovic R, Kostic S. Balkan endemic nephropathy: Slowed progression of kidney disease by avoidance of etiological factors (letter) Nephron. 1999;83:85–86. doi: 10.1159/000045477. [DOI] [PubMed] [Google Scholar]
  • 18.Bukvic D, Jankovic S, Dukanovic L, Marinkovic J. Survival of Balkan endemic nephropathy patients. Nephron. 2000;86:463–466. doi: 10.1159/000045835. [DOI] [PubMed] [Google Scholar]

Articles from European Journal of Epidemiology are provided here courtesy of Nature Publishing Group

RESOURCES